407 related articles for article (PubMed ID: 17415039)
1. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda.
Gray RH; Li X; Kigozi G; Serwadda D; Nalugoda F; Watya S; Reynolds SJ; Wawer M
AIDS; 2007 Apr; 21(7):845-50. PubMed ID: 17415039
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of adult circumcision in a resource-rich setting for HIV prevention among men who have sex with men.
Anderson J; Wilson D; Templeton DJ; Grulich A; Carter R; Kaldor J
J Infect Dis; 2009 Dec; 200(12):1803-12. PubMed ID: 19909084
[TBL] [Abstract][Full Text] [Related]
3. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
[TBL] [Abstract][Full Text] [Related]
4. Alcohol use before sex and HIV acquisition: a longitudinal study in Rakai, Uganda.
Zablotska IB; Gray RH; Serwadda D; Nalugoda F; Kigozi G; Sewankambo N; Lutalo T; Mangen FW; Wawer M
AIDS; 2006 May; 20(8):1191-6. PubMed ID: 16691071
[TBL] [Abstract][Full Text] [Related]
5. Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: a cost-effectiveness analysis.
Dowdy DW; Sweat MD; Holtgrave DR
AIDS; 2006 Oct; 20(16):2091-8. PubMed ID: 17053355
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level.
Alsallaq RA; Cash B; Weiss HA; Longini IM; Omer SB; Wawer MJ; Gray RH; Abu-Raddad LJ
Epidemics; 2009 Sep; 1(3):139-52. PubMed ID: 21352761
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine.
Vickerman P; Kumaranayake L; Balakireva O; Guinness L; Artyukh O; Semikop T; Yaremenko O; Watts C
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S89-102. PubMed ID: 16735956
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of male circumcision for HIV prevention in a South African setting.
Kahn JG; Marseille E; Auvert B
PLoS Med; 2006 Dec; 3(12):e517. PubMed ID: 17194197
[TBL] [Abstract][Full Text] [Related]
9. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
Holtgrave DR
J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a behavioral intervention for seropositive youth.
Lee MB; Leibowitz A; Rotheram-Borus MJ
AIDS Educ Prev; 2005 Apr; 17(2):105-18. PubMed ID: 15899749
[TBL] [Abstract][Full Text] [Related]
11. The estimated burden of HIV/AIDS in Uganda, 2005-2010.
Hladik W; Musinguzi J; Kirungi W; Opio A; Stover J; Kaharuza F; Bunnell R; Kafuko J; Mermin J
AIDS; 2008 Feb; 22(4):503-10. PubMed ID: 18301063
[TBL] [Abstract][Full Text] [Related]
12. Medical male circumcision for HIV/AIDS prevention in Uganda - the cost of disposable versus re-usable circumcision kits.
Kuznik A; Lamorde M; Sekavuga DB; Picho B; Coutinho A
Trop Doct; 2012 Jan; 42(1):5-7. PubMed ID: 22223725
[TBL] [Abstract][Full Text] [Related]
13. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
Binagwaho A; Pegurri E; Muita J; Bertozzi S
PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.
Kumaranayake L; Vickerman P; Walker D; Samoshkin S; Romantzov V; Emelyanova Z; Zviagin V; Watts C
Addiction; 2004 Dec; 99(12):1565-76. PubMed ID: 15585048
[TBL] [Abstract][Full Text] [Related]
15. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
Gray RH; Kigozi G; Serwadda D; Makumbi F; Watya S; Nalugoda F; Kiwanuka N; Moulton LH; Chaudhary MA; Chen MZ; Sewankambo NK; Wabwire-Mangen F; Bacon MC; Williams CF; Opendi P; Reynolds SJ; Laeyendecker O; Quinn TC; Wawer MJ
Lancet; 2007 Feb; 369(9562):657-66. PubMed ID: 17321311
[TBL] [Abstract][Full Text] [Related]
16. Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.
Gray RH; Li X; Wawer MJ; Gange SJ; Serwadda D; Sewankambo NK; Moore R; Wabwire-Mangen F; Lutalo T; Quinn TC;
AIDS; 2003 Sep; 17(13):1941-51. PubMed ID: 12960827
[TBL] [Abstract][Full Text] [Related]
17. Designing and usage of a low-cost penile model for male medical circumcision skills training in Rakai, Uganda.
Kigozi G; Nkale J; Wawer M; Anyokorit M; Watya S; Nalugoda F; Kagaayi J; Kiwanuka N; Mwinike J; Kighoma N; Nalwoga GK; Nakigozi GF; Katwalo H; Serwadda D; Gray RH
Urology; 2011 Jun; 77(6):1495-7. PubMed ID: 21296389
[TBL] [Abstract][Full Text] [Related]
18. Cost analysis of neonatal circumcision in a large health maintenance organization.
Schoen EJ; Colby CJ; To TT
J Urol; 2006 Mar; 175(3 Pt 1):1111-5. PubMed ID: 16469634
[TBL] [Abstract][Full Text] [Related]
19. Costing adult male circumcision in high HIV prevalence, low circumcision rate countries.
Fieno JV
AIDS Care; 2008 May; 20(5):515-20. PubMed ID: 18484318
[TBL] [Abstract][Full Text] [Related]
20. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda.
Kigozi G; Watya S; Polis CB; Buwembo D; Kiggundu V; Wawer MJ; Serwadda D; Nalugoda F; Kiwanuka N; Bacon MC; Ssempijja V; Makumbi F; Gray RH
BJU Int; 2008 Jan; 101(1):65-70. PubMed ID: 18086100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
